For the Inventor, By the Inventor

Enter assignee name

Madison, WI, United States of America

Arrowhead Madison, Inc.

Calculating rank

USPTO Granted Patents = 19

% Expired Patents = 31.6

Forward Citations = 418

Loading Chart...

Loading Chart...

33 inventors (with patents filed for the assignee):

Darren H Wakefield (16 out of 58 patents)

David B Rozema (16 out of 83 patents)

David L Lewis (10 out of 44 patents)

4. Jon Asher Wolff (8 out of 97 patents)

5. Peter Mohr (6 out of 83 patents)

6. Torsten Hoffmann (6 out of 40 patents)

7. Philipp Hadwiger (6 out of 52 patents)

8. Eric Argirios Kitas (6 out of 31 patents)

9. Jeffrey Carlson (5 out of 21 patents)

10. Andrei V Blokhin (5 out of 25 patents)

11. Jonathan D Benson (5 out of 14 patents)

12. Ingo Roehl (4 out of 18 patents)

13. James E Hagstrom (4 out of 64 patents)

14. Hans Martin Mueller (4 out of 9 patents)

15. Guenther Ott (3 out of 6 patents)

19 patents: Sort by Forward Citations

1. 9481661 - Disubstituted maleic anhydrides with altered kinetics of ring closure (2016-11-01),

2. 9345775 - Compositions for targeted delivery of siRNA (2016-05-24),

3. 9249179 - Galactose cluster-pharmacokinetic modulator targeting moiety for siRNA (2016-02-02),

4. 9107957 - Peptide-based in vivo siRNA delivery system (2015-08-18),

5. 9089611 - [object Object] (2015-07-28),

6. 9011919 - Compositions for targeted delivery of siRNA (2015-04-21),

7. 8933047 - Poly(acrylate) polymers for in vivo nucleic acid delivery (2015-01-13),

8. 8932572 - Poly(vinyl ester) polymers for in vivo nucleic acid delivery (2015-01-13),

9. 8809293 - Compositions and methods for inhibiting gene expression of hepatitis B virus (2014-08-19),

10. 8802773 - In vivo polynucleotide delivery conjugates having enzyme sensitive linkages (2014-08-12),

11. 8658211 - Polyconjugates for in vivo delivery of polynucleotides (2014-02-25),

12. 8541548 - Compounds and methods for reversible modification of biologically active molecules (2013-09-24),

13. 8501930 - Peptide-based in vivo siRNA delivery system (2013-08-06),

14. 8426554 - In vivo polynucleotide delivery conjugates having enzyme sensitive linkages (2013-04-23),

15. 8313772 - Compositions for targeted delivery of siRNA (2012-11-20),

Company Overview

Arrowhead Madison, Inc. is a biotechnology company based in Madison, Wisconsin, focused on developing innovative therapies for serious diseases. The organization specializes in RNA-targeted therapeutics, leveraging its proprietary platform to create treatments that address unmet medical needs. With a commitment to advancing healthcare, Arrowhead Madison engages in extensive research and development to explore novel approaches in the field of molecular medicine, aiming to improve patient outcomes through cutting-edge science.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

19 Patents

#46 in Madison, WI

#401 in Wisconsin

#17,154 in US

#32,705 in the World

Madison, WI, United States of America

Arrowhead Madison, Inc.

Forward Citations = 418

33 inventors:

Darren H Wakefield (16 out of 58 patents)

David B Rozema (16 out of 83 patents)

David L Lewis (10 out of 44 patents)

4. Jon Asher Wolff (8 out of 97 patents)

5. Peter Mohr (6 out of 83 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Arrowhead Madison, Inc.. Retrieved from https://idiyas.com/company/arrowhead-madison

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…